Sara El Ashkar

The BET Family of Proteins Targets Moloney Murine Leukemia Virus Integration near Transcription Start Sites

Jan De Rijck, Christine de Kogel, Jonas Demeulemeester et al. · Cell Reports · 2013 · 174 citations · Full text

LEDGF/p75 is dispensable for hematopoiesis but essential for MLL-rearranged leukemogenesis

Sara El Ashkar, Juerg Schwaller, Tim Pieters et al. · Blood · 2017 · 56 citations · Full text

Validation and Structural Characterization of the LEDGF/p75–MLL Interface as a New Target for the Treatment of MLL-Dependent Leukemia

Kateřina Čermáková, Petr Těšina, Jonas Demeulemeester et al. · Cancer Research · 2014 · 52 citations · Full text

Mixed-phenotype Acute Leukemia, Molecular Biology, Cancer Biology +20

BET-independent MLV-based Vectors Target Away From Promoters and Regulatory Elements

Sara El Ashkar, Jan De Rijck, Jonas Demeulemeester et al. · Molecular Therapy — Nucleic Acids · 2014 · 48 citations · Full text

Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in <i>KMT2A</i>- and <i>NPM1</i>-altered leukemias

Min Chul Kwon, Jan Willem Thuring, Olivier Querolle et al. · Blood · 2024 · 48 citations · Full text